Minimal and Null Predictive Effects for the Most Popular Blood Biomarkers of Cardiovascular Disease

Problems With Risk Reclassification Methods for Evaluating Prediction Models

(2011) M. S. Pepe   AMERICAN JOURNAL OF EPIDEMIOLOGY

Risk factors and interventions with statistically significant tiny effects

(2011) G. C. Siontis et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Commentary: Reporting standards are needed for evaluations of risk reclassification

(2011) M. S. Pepe et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Use of reclassification for assessment of improved prediction: an empirical evaluation

(2011) Ioanna Tzoulaki et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Comparison of Effect Sizes Associated With Biomarkers Reported in Highly Cited Individual Articles and in Subsequent Meta-analyses

(2011) John P. A. Ioannidis   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials

(2011) Michael V Holmes et al.   LANCET

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk

(2011) Georg B. Ehret et al.   NATURE

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease

(2011) Heribert Schunkert et al.   NATURE GENETICS

Reconciling the Evidence on Serum Homocysteine and Ischaemic Heart Disease: A Meta-Analysis

(2011) David S. Wald et al.   PLoS One

2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults

(2010) et al.   CIRCULATION

Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study

(2010) Michael Preuss et al.   Circulation-Cardiovascular Genetics

Biological, clinical and population relevance of 95 loci for blood lipids

(2010) Tanya M. Teslovich et al.   NATURE

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

(2010) Michael J. Pencina et al.   STATISTICS IN MEDICINE

B-Type Natriuretic Peptides and Cardiovascular Risk

(2009) Emanuele Di Angelantonio et al.   CIRCULATION

Criteria for Evaluation of Novel Markers of Cardiovascular Risk

(2009) Mark A. Hlatky et al.   CIRCULATION

Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease

(2009) Paul Elliott   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Assessment of Claims of Improved Prediction Beyond the Framingham Risk Score

(2009) Ioanna Tzoulaki   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Major Lipids, Apolipoproteins, and Risk of Vascular Disease

(2009) The Emerging Risk Factors Collaboration*   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

(2009)   LANCET

Homocysteine Level and Coronary Heart Disease Incidence: A Systematic Review and Meta-analysis

(2009) Linda L. Humphrey et al.   MAYO CLINIC PROCEEDINGS

C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction

(2008) Paul M Ridker et al.   CIRCULATION

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Why Current Publication Practices May Distort Science

(2008) Neal S Young et al.   PLOS MEDICINE

Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review

(2008) John Danesh et al.   PLOS MEDICINE